XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://www.bigmoleculewatch.com/2018/01/31/recommendations-use-biosimilars-treat-rheumatological-diseases/20%Monthly2018-03-13 22:58
https://www.bigmoleculewatch.com/2018/01/30/ohnson-johnson-comments-remicade-sales-decline-biosimilar-competition/20%Monthly2018-03-13 23:00
https://www.bigmoleculewatch.com/2018/01/30/pipeline-updates-clover-pfizer-mylan-biocon/20%Monthly2018-03-13 23:01
https://www.bigmoleculewatch.com/2018/01/26/deal-watch-xbrane-biopharma-signs-letter-intent-cr-pharma-regarding-xlucane/20%Monthly2018-03-13 23:02
https://www.bigmoleculewatch.com/2018/01/25/sandoz-announces-collaboration-biocon-next-generation-biosimilars/20%Monthly2018-03-13 23:03
https://www.bigmoleculewatch.com/2018/01/25/new-bpcia-litigations-regarding-celltrions-trastuzumab-rituximab-biosimilars/20%Monthly2018-06-22 00:11
https://www.bigmoleculewatch.com/2018/01/25/amgen-files-reply-support-motion-transfer-bevacizumab-action-california/20%Monthly2018-03-16 17:43
https://www.bigmoleculewatch.com/2018/01/24/federal-circuit-affirms-invalidation-patent-covering-remicade-infliximab/20%Monthly2018-07-25 14:27
https://www.bigmoleculewatch.com/2018/01/24/brazilian-society-clinical-oncology-publishes-position-statement-biosimilars-oncology/20%Monthly2018-03-16 17:45
https://www.bigmoleculewatch.com/2018/01/23/alteogen-reports-similarity-biosimilar-alt-l9-eylea/20%Monthly2018-03-16 17:46
https://www.bigmoleculewatch.com/2018/01/22/first-etanercept-biosimilar-receive-sales-approval-japan/20%Monthly2018-03-16 17:47
https://www.bigmoleculewatch.com/2018/01/19/cd-cal-stays-dismissal-amgen-dj-complaint-pending-delaware-decision-genentechs-motion-transfer-mvasi-litigation/20%Monthly2018-03-16 17:48
https://www.bigmoleculewatch.com/2018/01/18/samsung-bioepiss-etanercept-biosimilar-said-less-immunogenic-enbrel/20%Monthly2018-03-16 17:50
https://www.bigmoleculewatch.com/2018/01/18/fda-accepts-sandoz-abla-adalimumab-biosimilar/20%Monthly2018-03-16 17:51
https://www.bigmoleculewatch.com/2018/01/16/amgens-motion-to-dismiss-genentechs-complaint-in-the-delaware-mvasi-litigation/20%Monthly2018-03-21 14:52
https://www.bigmoleculewatch.com/2018/01/16/fda-announces-release-2018-strategic-policy-roadmap/20%Monthly2018-03-16 17:51
https://www.bigmoleculewatch.com/2018/01/12/france-aims-80-biosimilar-penetration-2022/20%Monthly2018-03-16 17:52
https://www.bigmoleculewatch.com/2018/01/11/federal-circuit-holds-that-ptabs-time-bar-determinations-are-appealable/20%Monthly2018-03-16 17:53
https://www.bigmoleculewatch.com/2018/01/10/update-biosimilar-testing-cinfa-mylanbiocon-sandoz/20%Monthly2018-03-16 17:53
https://www.bigmoleculewatch.com/2018/01/08/wells-fargo-analyst-humira-price-increase-add-1-2-billion-u-s-healthcare-market/20%Monthly2018-03-16 17:55
https://www.bigmoleculewatch.com/2018/01/08/oregon-passes-biosimilar-automatic-substitution-law-2/20%Monthly2018-03-16 17:54
https://www.bigmoleculewatch.com/2018/01/05/hetero-glenmark-launch-adalimumab-biosimilars-india/20%Monthly2018-03-16 17:58
https://www.bigmoleculewatch.com/2018/01/05/bristol-myers-squibb-bavarian-nordic-enzo-biochem-file-amicus-brief-supporting-amgens-petition-en-banc-consideration-written-description-enablement-issues-praluent-l/20%Monthly2018-07-25 14:29
https://www.bigmoleculewatch.com/2018/01/05/study-concludes-samsung-bioepis-adalimumab-biosimilar-equivalent-humira/20%Monthly2018-03-16 17:59
https://www.bigmoleculewatch.com/2018/01/04/fda-publishes-best-practices-communication-ind-sponsors-fda-drug-development/20%Monthly2018-03-16 18:00
https://www.bigmoleculewatch.com/2018/01/04/momenta-and-mylan-collaborating-m710/20%Monthly2018-03-16 18:00
https://www.bigmoleculewatch.com/2018/01/03/article-regarding-2018-biosimilar-litigation-landscape-bmw-editors/20%Monthly2018-07-24 14:04
https://www.bigmoleculewatch.com/2018/01/03/big-molecule-watch-team-shares-biosimilars-landscape-2018-at-j-p-morgan-healthcare-conference/20%Monthly2018-07-24 14:05
https://www.bigmoleculewatch.com/2018/01/02/mylan-biocon-gain-approval-trastuzumab-biosimilar-brazil/20%Monthly2018-03-16 18:01